Quote from: FTMax on February 26, 2017, 05:58:20 PM
If they are following WPATH standards of care, they are not simultaneously following informed consent. They are two different models.
The VA does what it does. I may have been mistaken in regards to the WPATH reference as I cannot now find a reference to it. I did find a reference to informed consent.
This is from the VHA Direct 2013-003 Q&A
VHA DIRECTIVE 2013-003 February 8, 2013
A-3
8. What are the guidelines for clinical care and the informed consent process?
a. Effective clinical care for transgender and intersex patients ideally involves an interdisciplinary, coordinated treatment approach with special attention to the needs of the individual patient and collaboration among multiple specialties, notably: gynecology, mental health, primary and specialty care, women's health, pharmacy, and urology. For all treatments and procedures, informed consent and shared decision-making needs to be the basis for individualized care that weighs the possible benefits and harms, with an emphasis on the lowest (safest) dose to achieve benefits.
b. For treatment plans that include cross-sex hormone therapy, VA clinicians must, consistent with requirements of informed consent (VHA Handbook 1004.01), discuss the risks, benefits, and limitations of cross-sex hormone therapy with the patient. Signature consent is not required for cross-sex hormone therapy. Ongoing monitoring of treatment is required.
Hugs,
Jeanette